A patient with moderate knee osteoarthritis and Chronic Kidney Disease stage 3b (eGFR 35 ml/min/1.73m²) finds Paracetamol 1g QDS insufficient for pain relief. According to NICE guidelines on osteoarthritis, what is the most appropriate next step to consider for pharmacological management?